Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors

Overview of attention for article published in Cancer Research, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 3 X users

patent: 9 patents

Readers on

mendeley: 33 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Protein tyrosine kinase 6 (PTK6) degradation / disruption compounds and methods of use

Grant US-12678507-B2

United States of America

14 Jul 2026

Heterobifunctional compounds as degraders of HPK1

Grant US-12465648-B2

United States of America

11 Nov 2025

Compositions and methods for treating EZH2-mediated cancer

Grant US-12274697-B2

United States of America

15 Apr 2025

WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use

Grant US-12110295-B2

United States of America

08 Oct 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.